Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nexalin Technology, Inc. - Common Stock
(NQ:
NXL
)
0.9201
-0.1599 (-14.81%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nexalin Technology, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders
March 03, 2025
Patent Strengthens Nexalin’s Intellectual Property Portfolio and Highlights the Potential of DIFS™ Technology in Addressing Substance Use Disorders, Including Opioids, Alcohol, Cocaine and...
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Nexalin Technology Announces Initiation of Patient Recruitment for UCSD’s TBI & PTSD Clinical Study Following IRB Approval
February 28, 2025
HALO™ Clarity Devices Successfully Shipped for First Phase of Clinical Trials
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Nexalin Technology Welcomes General Wesley Clark to Military & Government Advisory Board
February 26, 2025
From
Nexalin Technology, Inc.
Via
GlobeNewswire
(NXL) - Analyzing Nexalin Technology's Short Interest
↗
November 07, 2024
Via
Benzinga
Nexalin Technology Announces UCSD IRB Approval for use of HALO™ Clarity in Clinical Trials for mTBI and PTSD Treatment
February 18, 2025
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Nexalin Appointed as Industry Co-Chair of National TBI Registry Coalition
February 10, 2025
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study
February 03, 2025
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session, Today, January 23
January 23, 2025
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Nexalin Technology CEO Mark White Issues Letter to Shareholders Highlighting Recent Achievements and Outlook for 2025
January 14, 2025
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Nexalin Technology Completes Phase 1of its Innovative Virtual Clinic
December 23, 2024
AI Components for Electronic Data Capture and Patient Monitoring to be Integrated into Phase 2
From
Nexalin Technology, Inc.
Via
GlobeNewswire
New Peer-Reviewed Publication Validates Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Technology, Reinforcing Leadership in High-Growth Neuromodulation Market
November 26, 2024
Report Highlights Nexalin’s Unique Non-Invasive Solution Addressing Deep Brain Dysfunction, Positioned to Revolutionize Mental Health Treatment
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results
↗
November 11, 2024
Via
Benzinga
Topics
Stocks
Nexalin Technology CEO Provides Letter to Shareholders
November 11, 2024
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on November 5th
November 01, 2024
From
Nexalin Technology, Inc.
Via
GlobeNewswire
Nexalin Technology Regains Compliance with Nasdaq Continued Listing Requirements
November 01, 2024
From
Nexalin Technology, Inc.
Via
GlobeNewswire
LOBO EV and Nexalin Technology Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
November 01, 2024
Via
ACCESSWIRE
Nexalin Technology Announces Landmark Study on Alzheimer's Disease and Deep Intracranial Frequency Stimulation Published in Journal of Alzheimer's Disease
October 28, 2024
New Data Confirms DIFS Improves Cognitive Function and Restores Brain Activity in Alzheimer's Patients
From
Nexalin Technology, Inc.
Via
GlobeNewswire
EXCLUSIVE: Nexalin Technology Says New Data Confirms Implantable Device Improves Cognitive Function, Restores Brain Activity in Alzheimer's Patients
↗
October 28, 2024
Nexalin says the study published in the Journal of Alzheimer's Disease shows DIFS may enhance cognition in mild Alzheimer's patients.
Via
Benzinga
NASDAQ Stocks Under $1 to Watch in October 2024: LGCB, KAVL, NXL, NXU, FAMI
October 25, 2024
Via
AB Newswire
Topics
Economy
Electric Vehicles
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 25, 2024
Via
Benzinga
Nexalin Technology and Calidi Biotherapeutics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
October 25, 2024
Via
ACCESSWIRE
Nexalin Technology Announces Planned Clinical Trial Utilizing Gen-3 Halo Headset in Partnership with UC San Diego & San Diego VA
October 22, 2024
From
Nexalin Technology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
October 17, 2024
Via
Benzinga
New Study Shows Nexalin’s Deep Intracranial Frequency Stimulation (DIFS) Significantly Improves Memory and Cognitive Function in Alzheimer’s Patients
October 17, 2024
Groundbreaking Trial Reveals DIFS Increases Neural Activity and Blood Flow in the Hippocampus, Offering Hope for Alzheimer’s Treatment
From
Nexalin Technology, Inc.
Via
GlobeNewswire
EXCLUSIVE: Nano-Cap Nexalin's Drug-Free Alternative For Alzheimer's Shows Improved Memory, Cognitive Function In Small Study
↗
October 17, 2024
Nexalin Technology's clinical trial results highlight notable cognitive improvements in Alzheimer's patients using Deep Intracranial Frequency Stimulation technology. The study showed significant...
Via
Benzinga
Nexalin Technology Appoints Carolyn Shelton as Senior Vice President of Clinical, Quality & Regulatory Affairs
October 14, 2024
Veteran medical device executive to drive regulatory and clinical strategy as Nexalin advances drug-free Deep Intracranial Frequency Stimulation (DIFS) technology for mental health treatment
From
Nexalin Technology, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
October 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
October 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
October 08, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
